- Home
- STTK vs ATLO Comparison
STTK vs ATLO Comparison
Compare STTK & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- ATLO
- Stock Information
- Founded
- STTK 2016
- ATLO 1903
- Country
- STTK United States
- ATLO United States
- Employees
- STTK N/A
- ATLO N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- ATLO Major Banks
- Sector
- STTK Health Care
- ATLO Finance
- Exchange
- STTK Nasdaq
- ATLO Nasdaq
- Market Cap
- STTK 173.6M
- ATLO 174.1M
- IPO Year
- STTK 2020
- ATLO N/A
- Fundamental
- Price
- STTK $3.65
- ATLO $18.40
- Analyst Decision
- STTK Strong Buy
- ATLO
- Analyst Count
- STTK 3
- ATLO 0
- Target Price
- STTK $10.67
- ATLO N/A
- AVG Volume (30 Days)
- STTK 122.9K
- ATLO 13.9K
- Earning Date
- STTK 11-07-2024
- ATLO 10-18-2024
- Dividend Yield
- STTK N/A
- ATLO 5.46%
- EPS Growth
- STTK N/A
- ATLO N/A
- EPS
- STTK N/A
- ATLO 1.06
- Revenue
- STTK $4,123,999.00
- ATLO $51,275,000.00
- Revenue This Year
- STTK $164.45
- ATLO N/A
- Revenue Next Year
- STTK N/A
- ATLO N/A
- P/E Ratio
- STTK N/A
- ATLO $17.46
- Revenue Growth
- STTK 380.09
- ATLO N/A
- 52 Week Low
- STTK $1.33
- ATLO $15.01
- 52 Week High
- STTK $11.76
- ATLO $22.50
- Technical
- Relative Strength Index (RSI)
- STTK 50.03
- ATLO 47.56
- Support Level
- STTK $3.63
- ATLO $18.27
- Resistance Level
- STTK $3.94
- ATLO $18.69
- Average True Range (ATR)
- STTK 0.23
- ATLO 0.48
- MACD
- STTK 0.04
- ATLO 0.08
- Stochastic Oscillator
- STTK 49.12
- ATLO 56.39
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.